Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Identix (IDNX) -- Ignore unavailable to you. Want to Upgrade?

To: David who wrote (12619)	3/3/1999 3:45:00 PM
From: David	Read Replies (1) \| Respond to of 26039

Here's an unusually realistic post from the Yahoo NRID thread: messages.yahoo.com@m2.yahoo.com His point, further described in a somewhat earlier post, is that corporate buyers of security products are not necessarily looking for the best software as much as they are looking for a guarantee of adequate technical support -- which, of course, NRID is not in position to give compared to bigger competitors like IDX. That is why having partners like Oracle and Compaq is important to IDX in the marketplace. If you can't provide support in out years, you will be largely confined to the very small sales channels that NRID is in fact using. The large channels are just beginning to open up, and IDX is in the best position to sell bio-ID in significant quantities. I've given up trying to predict specific revenue and earnings targets for the time being, since any one prediction can be overwhelmed with just a couple of major sales -- and they could start in April or November, or next year, and all of a sudden. But every sign is they will happen. IDX is not going to have to wait five years for those sales.